. .

 
Zuruecksetzen

Suchergebnis - DANAHER CORP. REGISTERED SHARES DL -,01

Zeit Titel
24.07 10:04dpa-AFX: *BARCLAYS RAISES DANAHER PRICE TARGET TO 285 (270) USD - 'EQUAL WEIGHT'
24.07 10:04dpa-AFX: *BARCLAYS HEBT ZIEL FÜR DANAHER AUF 285 (270) USD - 'EQUAL WEIGHT'
23.07 15:43dpa-AFX: *DANAHER +6,8% - SPRINGEN DEUTLICH ÜBER 50-TAGE-LINIE
23.07 13:49dpa-AFX: Pre-market Movers: FEIM, TUSK, MIRA, CLRB, PII.
23.07 13:13dpa-AFX: AKTIEN-FLASH: Danaher mildert jüngsten Kurseinbruch von Sartorius etwas ab
23.07 13:04dpa-AFX: Danaher Q2 24 Earnings Conference Call At 8:00 AM ET
23.07 13:02dpa-AFX: *DANAHER NACH ZAHLEN VORBÖRSLICH FAST +7% - KLEINER SQUEEZE IN SARTORIUS + STEDIM
23.07 12:08dpa-AFX: *DANAHER EXPECTS FY NON-GAAP CORE REVENUE TO BE DOWN LOW-SINGLE DIGITS YEAR-OVER-YEAR
23.07 12:08dpa-AFX: *DANAHER EXPECTS Q3 NON-GAAP CORE REVENUE TO BE DOWN LOW-SINGLE DIGITS YEAR-OVER-YEAR
23.07 12:07dpa-AFX: *DANAHER Q2 NON-GAAP ADJ. EPS $1.72 VS $1.73 PRIOR YEAR
23.07 12:06dpa-AFX: *DANAHER Q2 NET EARNINGS $907 MLN OR $1.22/SHR VS $1.11 BLN OR $1.24/SHR PRIOR YEAR
23.07 12:03dpa-AFX: Danaher Corp. Reveals Decline In Q2 Profit
23.07 12:02dpa-AFX: *DANAHER Q2 REVENUES DECREASE 3.0% Y-O-Y TO $5.7 BLN AND NON-GAAP CORE REVENUE DECREASE 3.5%
17.07 13:31dpa-AFX: *DANAHER ANNOUNCES TWO NEW CENTERS OF INNOVATION IN DIAGNOSTICS TO TRANSFORM PRECISION MEDICINE DEVELOPMENT DANAHER
09.07 09:02dpa-AFX: *BECKMAN COULTER UNVEILS INTEGRATED CHEMISTRY AND IMMUNOASSAY ANALYZER
19.06 13:40dpa-AFX: *DANAHER APPOINTS JULIE SAWYER MONTGOMERY TO EVP FOR DIAGNOSTICS, EFFECTIVE AS OF JULY 1, 2024
05.06 13:01dpa-AFX: *DANAHER APPOINTS MARTIN STUMPE TO NEW ROLE OF CHIEF DATA & ARTIFICIAL INTELLIGENCE OFFICER
09.05 13:19dpa-AFX: *DANAHER LAUNCHES COLLABORATION WITH JOHNS HOPKINS UNIVERSITY TO IMPROVE NEUROLOGICAL DIAGNOSIS
07.05 22:18dpa-AFX: *DANAHER CORP. (DHR) DECLARES QUARTERLY DIVIDEND OF $ 0.27, RECORD DATE 6/28/2024
23.04 17:14dpa-AFX: Danaher Stock Climbs After Q1 Earnings Beats Estimates

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH